CT BIOPSY LUNG (LEFT) – Details
TECHNIQUE: Diagnostic CT BIOPSY LUNG (LEFT)
INDICATION: Metastatic lung cancer
Consent: The nature of the procedure, including its risks, benefits and alternatives was explained to the patient who understood and gave consent.
The patient was placed prone on the CT table. Targeted preprocedure CT images demonstrated a dominant left lower lung mass, not significantly changed compared to chest CT from 5/23/2021. This was identified as the biopsy target.
After identifying a direct path to the target, the overlying skin was prepped and draped in the usual sterile fashion. A “time-out” was performed prior to initiation of the procedure to reconfirm the patient’s name, date of birth, and site of procedure. 15 cc of 1% lidocaine were administered for local anesthesia.
Using CT guidance, a 19-gauge introducer needle was percutaneously placed in the target using posterior approach. The stylet was exchanged for a 22-gauge Chiba needle and aspirates were obtained for slides. Additional fine needle aspirates were collected in a vial filled with normal saline. Subsequently, multiple tissue cores were obtained using a 20-gauge spring-loaded device. Tissue samples were handed to the cytopathology technologist and research assistant.
Post procedure images demonstrated no significant hemorrhage or pneumothorax.
ANESTHESIA: Intravenous conscious sedation was administered by radiology nursing. Continuous hemodynamic and respiratory monitoring was performed, including the use of pulse oximetry.
START TIME: 8:15 AM
STOP TIME: 9:03 AM
Medications: As per medication administration record
CONDITION/COMPLICATIONS: The patient was brought to the radiology recovery room. Post procedure chest radiographs were obtained one hour and three hours after the procedure.
DISPOSITION: Oral and written post-procedure instructions were given.
Needle aspiration and core biopsy of left lung mass without immediate complications.